VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $751,000 | -39.9% | 51,700 | +1.4% | 0.01% | -44.4% |
Q3 2016 | $1,249,000 | +2.7% | 51,000 | -15.8% | 0.02% | 0.0% |
Q2 2016 | $1,216,000 | -80.6% | 60,600 | -2.1% | 0.02% | -80.9% |
Q4 2015 | $6,264,000 | -53.7% | 61,900 | -18.8% | 0.09% | -54.8% |
Q3 2015 | $13,538,000 | -14.6% | 76,200 | +6.7% | 0.21% | -13.7% |
Q2 2015 | $15,846,000 | +9.6% | 71,400 | -2.5% | 0.24% | +10.6% |
Q1 2015 | $14,461,000 | +25.2% | 73,200 | -9.0% | 0.22% | +21.1% |
Q4 2014 | $11,546,000 | +77.3% | 80,400 | +62.1% | 0.18% | +66.7% |
Q3 2014 | $6,513,000 | +24.2% | 49,600 | +19.8% | 0.11% | +18.7% |
Q2 2014 | $5,245,000 | -7.6% | 41,400 | -3.9% | 0.09% | -15.0% |
Q1 2014 | $5,679,000 | +23.2% | 43,100 | +9.7% | 0.11% | +16.3% |
Q4 2013 | $4,609,000 | +18.9% | 39,300 | +5.9% | 0.09% | +10.8% |
Q3 2013 | $3,876,000 | +42.7% | 37,100 | +17.4% | 0.08% | +62.7% |
Q2 2013 | $2,716,000 | – | 31,600 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Capital Analysts, LLC | 7,350 | $439,309,000 | 0.18% |
GOLDMAN SACHS GROUP INC | 2,996,127 | $179,078,000 | 0.07% |
MUFG Americas Holdings Corp | 52,285 | $3,125,000 | 0.06% |
Zurcher Kantonalbank (Zurich Cantonalbank) | 22,936 | $1,367,000 | 0.05% |
GOLDMAN SACHS GROUP INC | 419,100 | $25,050,000 | 0.01% |
AQR Capital Management | 35,829 | $2,141,000 | 0.01% |
HSBC HOLDINGS PLC | 33,669 | $2,009,000 | 0.01% |
GOLDMAN SACHS GROUP INC | 147,000 | $8,786,000 | 0.00% |
NOMURA HOLDINGS INC | 6,000 | $359,000 | 0.00% |
Twin Tree Management, LP | 455 | $27,000 | 0.00% |